Open AccessEvolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen
Author(s) -
Liqin Sun,
Jia-ye Liu,
Yun He,
Yang Zhou,
Liumei Xu,
Lukun Zhang,
Fang Zhao,
Xiaoning Liu,
Ying Song,
Tingzhi Cao,
Yi-mei Tian,
Man Rao,
Hui Wang
Publication year - 2020
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001245
Subject(s) - dyslipidemia , efavirenz , medicine , lamivudine , lopinavir , ritonavir , confidence interval , odds ratio , zidovudine , incidence (geometry) , abacavir , triglyceride , gastroenterology , cholesterol , human immunodeficiency virus (hiv) , viral load , virology , antiretroviral therapy , hepatitis b virus , obesity , virus , viral disease , physics , optics
Lipid abnormalities are prevalent among people living with human immunodeficiency virus (HIV) (PLWH) and contribute to increasing risk of cardiovascular events. This study aims to investigate the incidence of dyslipidemia and its risk factors in PLWH after receiving different first-line free antiretroviral regimens.